TG Therapeutics | TGTX - سرمایه و ذخایر





سرمایه و ذخایر تغییر دادن تاریخ
AbbVie USD -3.27B 628M 2025-12
Alaunos Therapeutics USD 2.8M 858K 2025-09
Amgen USD 8.66B 961M 2025-12
Ardelyx USD 166.95M 12.67M 2025-12
Arrowhead Research USD 568.42M 102.37M 2025-12
Bayer EUR 25.95B 3.75B 2025-12
Biogen USD 18.21B 573.5M 2025-09
Corcept Therapeutics USD 647.8M 15.9M 2025-12
Curis USD -13.99M 7.38M 2025-06
Gilead Sciences USD 22.62B 1.16B 2025-12
Infinity Pharmaceuticals USD -37.41M 9.08M 2023-06
J&J USD 78.47B 0 2025-09
Karyopharm Therapeutics USD -269.26M 30.33M 2025-09
Novartis USD 46.13B 1.38B 2025-12
Novavax USD -127.75M 28.92M 2025-12
PTC Therapeutics USD -205.31M 49.56M 2025-12
Puma Biotechnology USD 115.27M 10.55M 2025-09
Regeneron Pharmaceuticals USD 31.26B 299.1M 2025-12
Roche Holding CHF 33.8B 758M 2025-12
TG Therapeutics USD 648.02M 40.8M 2025-12
Verastem USD -15.53M 16.91M 2025-09
Vertex Pharmaceuticals USD 18.67B 1.35B 2025-12